PlainPharmaWatch

CMS Open Payments · Program Year 2024

Akcea Therapeutics, Inc.

Akcea Therapeutics, Inc. reported $19,218.61 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 1 transactions.

See the rankings → How this is sourced
$19.2K
All-tracks total
1
Transactions
0
Recipients
#1541
of 1,925 companies

Akcea Therapeutics, Inc. reported $19,218.61 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #1541 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer akcea-therapeutics-inc Akcea Therapeutics, Inc.

$19.2K · #1541/1,925 · 0.0% industry · PY2024

  • TOT $19.2K
  • RANK #1541
  • SHARE 0.0%
  • TXN 1
  • RCP 0
  • CAT 0
  • GEN n/a
  • PY 2024

Volume peers

Nearest volume peer: Lombart Brothers, Inc. ($19.3K)

Aero US Inc$19.3K3Shape Inc$19.3KLombart Brothers, Inc.$19.3KAkcea Therapeutics, Inc. (th…$19.2KNovabone Products$19.0K
All-tracks payment totals near Akcea Therapeutics, Inc. (CMS Open Payments PY2024)

Akcea Therapeutics, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Akcea Therapeutics, Inc.

$19,218.61: that is what Akcea Therapeutics, Inc. reported in payments to 0 physicians and teaching hospitals during Program Year 2024, spread across 1 transactions ($19.2K per transaction, $0.00 per recipient). The company sits at rank #1541 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Akcea Therapeutics, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Akcea Therapeutics, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.